Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Bone Biologics Corp. (BBLG) had Pre-Tax Income of $-0.74M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.74M |
|
-- |
|
-- |
|
$0.75M |
|
$-0.75M |
|
$0.01M |
|
|
Pre-Tax Income |
$-0.74M |
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.75M |
|
$-0.75M |
|
0.56M |
|
0.56M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$7.00M |
|
-- |
|
-- |
|
$7.00M |
|
$0.41M |
|
-- |
|
-- |
|
$0.41M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
1.69M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$6.64M |
|
$3.32M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.23% |
|
-11.23% |
|
-10.58% |
|
-11.23% |
|
$3.91 |
|
$-2.48 |
|
$-2.48 |
|